Atopic Dermatitis

Current Studies

Active | Recruiting

AbbVie
M19-850

PHASE: 3

STATUS: Recruiting

SUMMARY:

Study (interventional: open-label extension) investigating efficacy and safety of upadacitinib (oral) for atopic dermatitis in adults (after completion of M16-046).

COMPLETE DETAILS

Dermira
DRM06-AD 17

PHASE: 3

STATUS: Recruiting

SUMMARY:

COMPLETE DETAILS

Galderma
RD.06.SPR.118161

PHASE: 3

STATUS: Recruiting

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of nemolizumab (injection) versus placebo for atopic dermatitis in adolescent and adult patients.

COMPLETE DETAILS

Sanofi
OBS15333

PHASE:

STATUS: Recruiting

SUMMARY:

Study (observational) investigating the characteristics of atopic dermatitis in pediatric patients.

COMPLETE DETAILS

Active | Not Yet Recruiting

No “Active | Not Yet Recruiting” Studies

Active | Not Recruiting

AbbVie
M16-045

PHASE: 3

STATUS: Not Recruiting

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of upadacitinib (oral) versus placebo for atopic dermatitis in adolescent and adults.

COMPLETE DETAILS

AbbVie
M16-046

PHASE: 3b

STATUS: Not Recruiting

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of upadacitinib (oral) versus dupilumab (injection) for atopic dermatitis in adults.

COMPLETE DETAILS

AbbVie
M16-047

PHASE: 3

STATUS: Not Recruiting

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of upadacitinib (oral) combined with topical corticosteroids versus placebo for atopic dermatitis in adolescents and adults.

COMPLETE DETAILS

LEO Pharma
LP0162-1334

PHASE: 3

STATUS: Not Recruiting

SUMMARY:

Study investigating the efficacy and safety of tralokinumab (injection) versus placebo for atopic dermatitis in adolescents.

COMPLETE DETAILS

LEO Pharma
LP0162-1337

PHASE: 3

STATUS: Not Recruiting

SUMMARY:

Study (interventional: open-label extension) investigating the efficacy and safety of tralokinumab (injection) for atopic dermatitis in adolescents.

COMPLETE DETAILS

Pfizer
B7451015

PHASE: 3

STATUS: Not Recruiting

SUMMARY:

Study (interventional: open-label extension) investigating the efficacy and safety of abrocitinib (oral) with topical corticosteroids for atopic dermatitis in adult patients.

COMPLETE DETAILS

Pfizer
B7451050

PHASE: 3

STATUS: Not Recruiting

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of abrocitinib (oral) versus dupilumab (injection) with topical corticosteroids for atopic dermatitis in adult patients.

COMPLETE DETAILS

Prior Studies

AbbVie
ABT-494

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of upadacitinib [ABT-494] (oral) versus placebo for atopic dermatitis in adults.

AbbVie
M16-048

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of upadacitinib (oral) versus placebo for atopic dermatitis in adults.

Asana
ASN002

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of ASN002 (oral) versus placebo for atopic dermatitis in adults.

Asana
ASN002AD-201-EXT

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: open-label extension) investigating the efficacy and safety of ASN002 (oral) versus placebo for atopic dermatitis in adults.

Coherus
CHS-0214-05

PHASE:

STATUS: Completed

SUMMARY:

An open-label safety extension study (OLSES) evaluating the long-term safety and durability of response of CHS-0214 (CHS-0214-05)

Dermavant
RVT-501-2004

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of RVT-501 (topical) versus placebo for atopic dermatitis in children.

DS Biopharma
DS107

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of DS107 (topical) versus placebo for atopic dermatitis in adults.

Eli Lilly
I4V-MC-JAIW

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of baricitinib (oral) versus placebo for atopic dermatitis in adults.

Eli Lilly
I4V-MC-JAIX

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: open-label extension) investigating the efficacy and safety of baricitinib (oral) for atopic dermatitis in adults (after completion of BREEZE-AD5/Study JAIW).

Galderma
RD.03.SPR.114322

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of nemolizumab (injection) with topical corticosteroids for atopic dermatitis in adults.

Hoffmann-La Roche
GS29250

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of lebrikizumab (injection) versus placebo for atopic dermatitis in adults.

Incyte
INCB018424

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of ruxolitinib [INCB018424] (topical) versus placebo for atopic dermatitis in adults.

Incyte
INCB18424-303

PHASE: 3

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of ruxolitinib (topical) for atopic dermatitis in adolescents and adults.

LEO
LP0162-1339

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of tralokinumab (injection) with topical corticosteroids versus without topical corticosteroids for atopic dermatitis in adults.

LEO Pharma
LP0133-1275

PHASE: 2

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of delgocitinib (topical) for atopic dermatitis in adults.

Pfizer
B7451012

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of abrocitinib [PF-04965842] (oral) versus placebo for atopic dermatitis in adults.

Pfizer
B7451014

PHASE: 3

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of abrocitinib (oral) for atopic dermatitis in adolescents and adult.

Regeneron
R668-AD-1415

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of dupilumab (injection) for atopic dermatitis in adults.

Regeneron
R668-AD-1416

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of dupilumab (injection) for atopic dermatitis in adults.

Regeneron
REGN668

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: open-label extension) investigating the efficacy and safety of dupilumab (injection) for atopic dermatitis in adults (after completion of R668-AD-1415).

Regeneron
SOLO 2

PHASE:

STATUS: Completed

SUMMARY:

A phase 3 confirmatory study investigating the efficacy and safety of dupilumab monotherapy administered to adult patients with moderate-to-severe atopic

Regeneron
SOLO-CONTINUE

PHASE:

STATUS: Completed

SUMMARY:

A phase 3, randomized, double-blind, placebo-controlled study investigating the efficacy and safety of multiple dupilumab dose regimens administered as monotherapy for maintaining treatment response in patients with atopic dermatitis